A stool-based enema composed of a broad variety of microbes (RBX2660, Rebiotix/Ferring) was up to 84% effective in reducing recurrent Clostridioides difficile infection (rCDI) in a study of more than 720 adults with rCDI. Most responders had no occurrence of diarrhea for up to two years after treatment.
“Collectively, these data demonstrate that RBX2660 is consistently and sustainably effective for the reduction of rCDI in adult patients, as early as first recurrence, after receiving